39.30↑0.80 (2.08%)
12:00 AM,22nd Sep 2023BSE : 523144
NSE : MEDICAPS
Sector : Others
ISIN Code : INE442D01010
Last Updated: Sep 22 2023 | 12:00 AM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 18.19 |
All Time High Date | 27 Oct 1995 |
All Time Low | 1.78 |
All Time Low Date | 22 Feb 1999 |
Medi-caps was incorporated by S L Mittal in Aug.'83 as a private limited company and was converted into a public limited company in Mar.'86. Pharmaceutical companies procure empty hard gelatine capsules from Medi-caps for dosaged medicines meant for oral administration. The company is the second-largest manufacturer of empty hard gelatine capsules in India. It takes several years for a company manufacturing capsules to attain zero-defect in production and to fully normalise operations. Medi-caps can claim to have achieved this. In Apr.'95 the company offered 6.11 lac rights shares at a premium of Rs 116 to part-finance the Rs 9.19-cr expansion of its manufacturing facilities (from 2000 mln pa to 3440 mln pa) by installing four high-speed automatic capsule-making machines.The company's manufacturing unit is located in Pithampur Madhya Pradesh. The company's clientele include US Vitamins SOL Pharmaceuticals Dr Reddy's Laboratories Lupin Laboratories Aristo Pharmaceuticals etc. At present it has 40 clients. The other group company of Medi-caps is Medi-caps Finance which is engaged in finance related activities. In 1993 R C Mittal received the Glory of India International award. In 1995-96 the company enhanced the capacity of empty hard gelatine capsules by 2500 lac. The company received ISO 9002 Certification during 1998-99. It developed six sizes of the Hard Gelatin Capsules in 2002-03. The company is closely working on commissioning of 13th Machine with 100% automisation. During 2002-03 the company established the export market in countries like ChinaThailandDubaiMalaysiaSouth Africa and Philipines.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 49 |
EPS - TTM (₹) [S] | 0.00 |
P/E Ratio (X) [S] | 0.80 |
Face Value (₹) | 10 |
Latest Dividend (%) | 15.00 |
Latest Dividend Date | 20 Sep 2012 |
Dividend Yield (%) | - |
Book Value Share (₹) [S] | 49.00 |
P/B Ratio (₹) [S] | 0.80 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 38.03 40.40 |
Week Low/High | 36.60 41.00 |
Month Low/High | 36.11 41.00 |
Year Low/High | 30.62 53.00 |
All time Low/High | 0.13 91.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 4.58% | % | -2.70 | -2.57% |
1 Month | 3.48% | % | 1.21 | 1.43% |
3 Month | 3.80% | % | 4.38 | 4.81% |
6 Month | 10.18% | % | 13.66 | 15.00% |
1 Year | -14.94% | % | 11.65 | 11.60% |
3 Year | 87.59% | % | 74.93 | 76.39% |
Date | Client Name | Exchange | Transaction | Quantity | Price |
---|---|---|---|---|---|
03-03-2023 | KANWARINDERPAL SAHNI | BSE | BUY | 62449 | 38.37 |
03-03-2023 | KANWARINDERPAL SAHNI | BSE | SELL | 98 | 39.70 |
28-06-2021 | DIPAK KANAYALAL SHAH | BSE | SELL | 100000 | 42.70 |
09-03-2021 | ANAND VELUMANI | BSE | BUY | 80000 | 41.00 |
19-02-2021 | DIPAK KANAYALAL SHAH | BSE | SELL | 85736 | 28.83 |
07-03-2017 | DIPAK KANAYALAL SHAH | BSE | BUY | 121769 | 29.53 |
28-12-2015 | YUGA STOCKS AND COMMODITIES PRIVATE LIMITED | BSE | SELL | 127078 | 36.86 |
28-12-2015 | YUGA STOCKS AND COMMODITIES PRIVATE LIMITED | BSE | BUY | 73620 | 36.55 |
04-08-2015 | TAPAS GANGOPADHYAY | BSE | SELL | 83731 | 26.06 |
06-08-2010 | HEMANT SNEHKANT SHETH | BSE | SELL | 19685 | 79.19 |
Load More |
Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
---|
Category | Share(%) |
---|---|
Promoter | 50.13 |
Financial Institutions Banks | 0.02 |
Foreign Institutional Investors | 0.00 |
Insurance Companies | 0.00 |
Mutual Funds Uti | 0.01 |
Other Institutional Investors | 0.00 |
Indian Public | 44.74 |
Others Non Institutional Investors | 5.10 |
Custodians | 0.00 |
Announcement Date | Purpose | From | To | Remarks |
---|---|---|---|---|
Data Not Found |
Search for Price History
Date | Open | High | Low | Close | Shares | Trades |
---|---|---|---|---|---|---|
Data Not Found |
Load more
Chairman (Non-Executive) : R C Mittal
Managing Director : Alok K Garg
Non-Exec. & Independent Dir. : Pramod Fatehpuria
Non-Exec. & Independent Dir. : Ashok Omprakash Agrawal
Non Executive Director : Kusum Mittal
Independent Director : Dharmendra Solanki
Company Sec. & Compli. Officer : Abhishek Kumar
Director : Akshit Garg
Additional Director : Gajendra Singh
Registered Office: Mhow-Neemuch Road, Sector - I,Pithampur,Madhya Pradesh-454775 Ph: 91-07292-424242
Email:investors@medicaps.com